MICS: the European picture

Article

Feature includes: statistics providing a true picture of the number of European surgeons practising MICS; interviews with European experts; why you should adopt the technique; product showcase.

Key Points

So has industry satisfied today's cataract surgeon or does research and development still have some way to go? Naturally, there will always be room for improvement and research will continue to deliver innovative products; however, many do believe that surgeons now have the instruments necessary to allow them to offer patients a truly first-class MICS service. But are the surgeons convinced?

Belgian market intelligence firm, Tools for Growth, set about finding the answer. They assessed European surgeons' attitudes towards MICS, in the hope of finding out how the introduction of these new technologies has influenced the way they actually perform cataract surgery today.

By conducting, what we believe to be, the most comprehensive and insightful independent market research survey ever performed,1 we can now present the true picture of European cataract surgery today.

The market intelligence firm questioned 915 surgeons in France (n=180), Germany (n=200), the UK (n=175), Italy (n=180) and Spain (n=180) at 720 sites across Europe, including public hospitals, private hospitals, eye clinics and private practices between January and February 2008. The distribution of surgeons questioned accurately mirrored the current climate, with approximately one-third of surgeons operating within a public hospital.

Not only were surgeons questioned about their current practice styles, but they were also asked to predict what style of surgery they believe they would be performing in two years' time.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.